Huron Consulting Group Inc. annual report, FY2014

Huron Consulting Group Inc. — FY2014 Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2014, filed February 24, 2015. The filing presents annual results; fourth-quarter information is included in the quarterly data. Huron provides operational and financial consulting, technology, analytics, restructuring, legal-process, healthcare, education, life-sciences, and business-advisory services through five operating segments.

Business Context

  • Revenue mix: Huron Healthcare 51%, Huron Legal 23%, Huron Education and Life Sciences 18%, and Huron Business Advisory 8%.
  • The company had 2,870 full-time employees and 133 client-serving managing directors at December 31, 2014.
  • 2014 acquisitions included The Frankel Group Associates, Vonlay, and Threshold Consulting. Enterprise Performance Management was moved from Education and Life Sciences to Business Advisory.

Financial Performance and Liquidity

Metric20142013Change
Revenue$811.3 million$720.5 million+12.6%
Operating income$123.0 million$119.9 million+2.6%
Operating margin15.2%16.6%Down 140 bps
Net income$79.1 million$66.4 million+19.0%
Diluted EPS$3.45$2.92+18.2%
Adjusted EBITDA$155.7 million$138.4 million+12.5%
Adjusted EBITDA margin19.2%19.2%Stable
Operating cash flow$146.5 million$115.3 million+27.1%
Cash and equivalents$256.9 million$58.1 million+342.0%
Total debt$356.6 million carrying value$168.8 millionIncreased primarily from convertible notes
  • Revenue growth included approximately $63.0 million from 2013 and 2014 acquisitions. Performance-based fees were $110.3 million, or approximately 13.5% of revenue; fixed-fee engagements represented 39.6%.
  • Total direct costs increased to 62.3% of revenue from 62.0%, while SG&A remained 19.2% of revenue. Higher personnel costs and lower litigation gains pressured operating margin.
  • Net income benefited materially from a 31.0% effective tax rate versus 41.5% in 2013, including a recognized net tax benefit of approximately $11.4 million from a “check-the-box” election.
  • Investing cash uses included $54.0 million for acquisitions, $25.9 million for capital expenditures, and $12.5 million for a convertible debt investment in Shorelight.
  • At year-end, working capital was $309.8 million. The company reported $242.4 million of unused borrowing capacity under its credit facility and no revolver borrowings.
  • The company repurchased $50.0 million of common stock during 2014 and had an additional $50.0 million authorization available at year-end. It pays no cash dividend.

Material Changes Versus 2013

  • Huron Healthcare revenue increased 15.9% to $415.8 million, while segment operating margin declined to 38.2% from 39.5%.
  • Huron Legal revenue was broadly flat at $183.6 million, but operating margin improved to 25.1% from 23.0%. Fourth-quarter performance was significantly below the first three quarters and management expectations following a sudden downturn related largely to settlements of government investigations connected with the credit crisis.
  • Education and Life Sciences revenue increased 1.6% to $146.0 million, with operating margin declining slightly to 24.8%.
  • Business Advisory revenue increased 81.3% to $62.8 million, driven principally by the EPM practice, and operating margin improved to 22.3% from 20.8%.
  • Debt increased following issuance of $250 million principal amount of 1.25% convertible senior notes due 2019. The company also reduced term-loan borrowings from $168.8 million to $143.8 million.
  • Restructuring charges increased to $3.4 million from $0.8 million, primarily for office consolidations, lease obligations, accelerated depreciation, and London workforce reductions.
  • No goodwill impairment was recorded in 2014. However, Huron Legal’s goodwill valuation cushion declined to 28% from 60% in its prior quantitative analysis.

Outlook, Risks, Contingencies, and Unusual Items

  • Management expected Huron Legal performance to improve during 2015. If improvement did not occur during the first half of 2015, an interim goodwill impairment analysis could have been required.
  • The filing does not provide a clear numerical 2015 revenue or earnings guidance range.
  • Management identified utilization, billing rates, hiring and retention, client renewals, performance-based fee timing, fixed-fee project profitability, acquisitions, goodwill impairment, technology availability, cybersecurity, healthcare regulation, and general economic conditions as key risks.
  • Client concentration declined: the top ten clients represented 27.3% of 2014 revenue versus 35.2% in 2013; no single client exceeded 10% of revenue.
  • Outstanding debt was secured by liens on substantially all assets and subsidiary equity. Credit agreement covenants included a minimum fixed-charge coverage ratio of 2.25x and maximum leverage ratio of 3.00x; reported year-end ratios were 4.50x and 0.98x, respectively.
  • Material litigation included a remaining Abu Dhabi defamation claim seeking $50 million and a potential Physiotherapy Associates Litigation Trust matter in which claimed damages could exceed $300 million. Management stated the claims were without merit and that no other litigation was expected to have a material adverse effect.
  • Subsequent events: Sky Analytics was acquired effective January 1, 2015, and Studer Group was acquired on February 12, 2015, for a base purchase price of $325 million, financed with cash and additional credit-facility borrowings. Purchase accounting and pro forma information were not complete at filing.
  • Convertible-note accounting generated $2.1 million of non-cash interest expense in 2014; management expected substantially higher 2015 amortization of debt discount and issuance costs.

Investor Verification Priorities

  • Verify the sustainability of 2014 growth excluding acquisition contributions and the effect of the tax election.
  • Track Huron Legal’s quarterly recovery, goodwill headroom, and any subsequent impairment analysis.
  • Assess leverage, debt-service requirements, covenant compliance, and funding for the Studer Group acquisition.
  • Evaluate cash conversion, collections of unbilled healthcare implementation work, and the growth in allowances for doubtful accounts and unbilled services.
  • Review the status and potential exposure from the Physiotherapy Associates and Abu Dhabi litigation matters.
  • Monitor performance-based fees, fixed-fee engagement margins, utilization, billing rates, and personnel costs.